1. Home
  2. LIXT vs DXLG Comparison

LIXT vs DXLG Comparison

Compare LIXT & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

N/A

Current Price

$2.88

Market Cap

26.5M

Sector

Health Care

ML Signal

N/A

Logo Destination XL Group Inc.

DXLG

Destination XL Group Inc.

HOLD

Current Price

$0.54

Market Cap

24.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
DXLG
Founded
2005
1976
Country
United States
United States
Employees
3
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
24.1M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
LIXT
DXLG
Price
$2.88
$0.54
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
41.6K
223.5K
Earning Date
05-11-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$435,017,000.00
Revenue This Year
N/A
$3.85
Revenue Next Year
N/A
$4.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.44
52 Week High
$6.09
$1.69

Technical Indicators

Market Signals
Indicator
LIXT
DXLG
Relative Strength Index (RSI) 48.07 50.45
Support Level $2.50 $0.49
Resistance Level $3.30 $0.57
Average True Range (ATR) 0.24 0.08
MACD 0.03 0.01
Stochastic Oscillator 51.56 38.24

Price Performance

Historical Comparison
LIXT
DXLG

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About DXLG Destination XL Group Inc.

Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.

Share on Social Networks: